KalVista Pharmaceuticals logo
KalVista Pharmaceuticals KALV
$ 10.27 -8.3%

Quarterly report 2023-Q4
added 03-11-2024

report update icon

KalVista Pharmaceuticals Depreciation & Amortization 2011-2024 | KALV

Annual Depreciation & Amortization KalVista Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
537 K 512 K 378 K 180 K 40 K 33 K 133 K 54 K 27 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
537 K 27 K 210 K

Quarterly Depreciation & Amortization KalVista Pharmaceuticals

2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 193 K - - - 158 K - - 397 K 259 K - - 382 K 261 K 128 K - 256 K 248 K 121 K - 129 K 153 K 50 K - 29 K 79 K 32 K - 26 K 8 K 34 K - 98 K 65 K 31 K - 37 K 20 K 10 K - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
397 K 8 K 128 K